Epidemiology, management and outcomes of large and small native joint septic arthritis in adults.
Native joint septic arthritis (NJSA) is poorly studied. We describe the epidemiology, treatment and outcomes of large joint (LNJSA) and small joint NJSA (SNJSA) in adults at Middlemore Hospital, Auckland, New Zealand. A coding-based retrospective study of patients ≥16 years old admitted between 2009 and 2014. Prosthetic joint infections were excluded. 543 NJSA episodes were included (302 LNJSA, 250 SNJSA). Only 40% had positive synovial fluid culture. Compared to SNJSA, LNJSA has higher incidence (13 vs. 8/100,000 person years), occurs in older, more comorbid patients, and is associated with greater rates of treatment failure (23% vs. 12%) and mortality, despite longer antibiotic treatment.Total incidence is higher than previously reported (21/100,000 person years), with marked inter-ethnic variation. Incidence rises with age (LNJSA only) and socioeconomic deprivation (LNJSA and SNJSA). Tobacco smokers and males are over-represented. The most commonly involved joints were knee (21%) and hand interphalangeal (20%). Staphylococcus aureus was the most common pathogen (53%). Mean antibiotic duration was 25 days for SNJSA and 40 days for LNJSA and mean number of surgical procedures was 1.5 and 1.6 procedures respectively.Treatment failure was independently associated with large joint NJSA, age, intra-articular non-arthroplasty prosthesis, and number of surgical procedures. This is the largest contemporary series of adult NJSA. SNJSA has better outcomes than LNJSA and may be able to be safely treated with shorter antimicrobial courses. Incidence is high, with significant ethnic and socioeconomic variation. Microbiological NJSA case ascertainment underestimates case numbers as it frequently excludes SNJSA.